Prevention of venous thromboembolism in immobilized neurological patients: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)

Thrombosis Research

Volumn 124, Issue 5, 2009, Pages

  Ageno, Walter ^a   Agnelli, Giancarlo ^b   Checchia, Giovanni ^c   Cimminiello, Claudio ^d   Paciaroni, Maurizio ^b   Palareti, Gualtiero ^e   Pini, Mario ^f   Piovella, Franco ^g   Pogliani, Enrico ^h   Testa, Sophie ⁱ  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c SANTA CORONA HOSPITAL   (Italy)

^d DESIO HOSPITAL   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f Ospedale di Fidenza   (Italy)

^g FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^h UNIVERSITY OF MILANO BICOCCA   (Italy)

ⁱ Emostasi e Trombosi   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; DEEP VEIN THROMBOSIS; DEGENERATIVE DISEASE; EVIDENCE BASED PRACTICE; GUILLAIN BARRE SYNDROME; HIGH RISK POPULATION; HUMAN; IMMOBILIZATION; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; LUNG EMBOLISM; MEDICAL SOCIETY; NEUROLOGIC DISEASE; NEUROMUSCULAR DISEASE; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCREENING TEST; SPINAL CORD DISEASE; SPINAL CORD INJURY; STROKE; THROMBOCYTE COUNT; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; HUMANS; IMMOBILIZATION; ITALY; NERVOUS SYSTEM DISEASES; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 70349876296     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.06.032     Document Type: Article

References (60)

1. Iorio A, Ageno W, Cosmi B, Imberti D, Lussana F, Siragusa S, et al. Guidelines of the Italian Society for Thrombosis and Haemostasis: objectives and methodology. Thromb Res, doi:10.1016/j.thromres.2009.05.014.
2. Davenport R.J., Dennis M.S., Wellwood I., and Warlow C.P. Complications following acute stroke. Stroke 27 (1996) 415-420
3. Kelly J., Rudd A., Lewis R., and Hunt B.J. Venous thromboembolism after acute stroke. Stroke 32 (2001) 262-267
4. Collaborative overview of randomized trials of antiplatelet therapy: III. Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration. BMJ 308 (1994) 235-246
5. Mazzone C., Chiodo G.F., Sandercock P., Miccio M., and Salvi R. Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev (2004) CD001922
6. Sandercock P., Counsell C., and Tseng M.C. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. Cochrane Database Syst Rev (2008) CD000119
7. Kamphuisen P.W., and Agnelli G. What is the optimal pharmacological prophylaxis for the prevention of deep vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?. Thromb Res 119 3 (2007) 265-274
8. Diener H.C., Ringelstein E.B., Von Kummer R., Landgraf H., Koppenhagen K., Harenberg J., et al. Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT Trial. Stroke 37 1 (2006) 139-144
9. Sherman D.G., Albers G.W., Bladin C., Fieschi C., Gabbai A.A., Kase C.S., et al. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischemic stroke (PREVAIL): an open label, randomized comparison. Lancet 369 9570 (2007) 1347-1355
10. Shorr A.F., Jackson W.L., Sherner J.H., and Moores L.K. Differences between low-molecular-weight and unfractionated heparin for venous thromboembolism prevention following ischemic stroke: a meta-analysis. Chest 133 1 (2008 Jan) 149-155
11. Berge E., and Sandercock P. Anticoagulants versus antiplatelet agents for acute ischaemic stroke. Cochrane Database Syst Rev (2002) CD003242
12. Goldstein J.N., Fazen L.E., Wendell L., Chang Y., Rost N.S., Snider R., et al. Risk of thromboembolism following acute intracerebral hemorrhage. Neurocrit Care 10 (2009) 28-34
13. Lacut K., Bressollette L., Le Gal G., Etienne E., De Tinteniac A., Renault A., et al. VICTORIAh (Venous Intermittent Compression and Thrombosis Occurrence Related to Intra-cerebral Acute hemorrhage) Investigators. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 65 (2005) 865-869
14. Dickmann U., Voth E., Schicha H., Henze T., Prange H., and Emrich D. Heparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral hemorrhage. Klin Wochenschr 66 (1988) 1182-1183
15. Boeer A., Voth E., Henze T., and Prange H.W. Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 54 (1991) 466-467
16. Harvey R.L., Lovell L.L., Belanger N., and Roth E.J. The effectiveness of anticoagulant and antiplatelet agents in preventing venous thromboembolism during stroke rehabilitation: a historical cohort study. Arch Phys Med Rehabil 85 (2004) 1070-1075
17. Tetri S., Hakala J., Juvela S., Saloheimo P., Pyhtinen J., Rusanen H., et al. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage. Thromb Res 123 (2008) 206-212
18. Kiphuth I.C., Staykov D., Kohrmann M., Struffert T., Richter G., Bardutzky J., et al. Early administration of low molecular weight heparin after spontaneous intracerebral hemorrhage. A safety analysis. Cerebrovasc Dis 27 (2009) 146-150
19. Burbridge B.E., Wallace J.K., Rajput A., and McCulloch L. Doppler ultrasonographic examination of the leg veins of patients with Parkinson disease. J Psychiatry Neurosci 24 (1999) 338-340
20. Gaber T.A., Kirker S.G., and Jenner J.R. Current practice of prophylactic anticoagulation in Guillain-Barre syndrome. Clin Rehabil 16 (2002) 190-193
21. Bredin C.P., Ball J.D., and Morton W.H. Thrombotic complications in acute polyneuritis. Br Med J 1 (1976) 837
22. Leese J. Thrombotic complications in acute polyneuritis. Br Med J 1 (1976) 585
23. Attia J., Ray J.G., Cook D.J., Douketis J., Ginsberg J.S., and Geerts W.H. Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med 161 (2001) 1268-1279
24. Aito S., Pieri A., D'Andrea M., Marcelli F., and Cominelli E. Primary prevention of deep venous thrombosis and pulmonary embolism in acute spinal cord injured patients. Spinal Cord 40 (2002) 300-303
25. Winemiller M.H., Stolp-Smith K.A., Silverstein M.D., and Therneau T.M. Prevention of venous thromboembolism in patients with spinal cord injury: effects of sequential pneumatic compression and heparin. J Spinal Cord Med 22 (1999) 182-191
26. Merli G.J., Crabbe S., Doyle L., Ditunno J.F., and Herbision G.J. Mechanical plus pharmacological prophylaxis for deep vein thrombosis in acute spinal cord injury. Paraplegia 30 (1992) 558-562
27. van H.E. Prevention of thrombophlebitis in spinal injury patients. Paraplegia 16 (1978) 332-335
28. Spinal Cord Injury Thromboprophylaxis Investigators. Prevention of venous thromboembolism in the acute treatment phase after spinal cord injury: a randomized, multicenter trial comparing low-dose heparin plus intermittent pneumatic compression with enoxaparin. J Trauma 54 (2003) 1116-1124
29. Spinal Cord Injury Thromboprophylaxis Investigators. Prevention of venous thromboembolism in the rehabilitation phase after spinal cord injury: prophylaxis with low-dose heparin or enoxaparin. J Trauma 54 (2003) 1111-1115
30. Thumbikat P., Poonnoose P.M., Balasubrahmaniam P., Ravichandran G., and McClelland M.R. A comparison of heparin/warfarin and enoxaparin thromboprophylaxis in spinal cord injury: the Sheffield experience. Spinal Cord 40 (2002) 416-420
31. Green D., Twardowski P., Wei R., and Rademaker A.W. Fatal pulmonary embolism in spinal cord injury. Chest 105 (1994) 853-855
32. Kulkarni J.R., Burt A.A., Tromans A.T., and Constable P.D. Prophylactic low dose heparin anticoagulant therapy in patients with spinal cord injuries: a retrospective study. Paraplegia 30 (1992) 169-172
33. Silver J.R., and Noori Z. Pulmonary embolism following anticoagulation therapy. Int Disabil Stud 13 (1991) 16-19
34. Green D., Lee M.Y., Lim A.C., Chmiel J.S., Vetter M., Pang T., et al. Prevention of thromboembolism after spinal cord injury using low-molecular-weight heparin. Ann Intern Med 113 (1990) 571-574
35. Green D., Lee M.Y., Ito V.Y., Cohn T., Press J., Filbrandt P.R., et al. Fixed- vs adjusted-dose heparin in the prophylaxis of thromboembolism in spinal cord injury. JAMA 260 (1988) 1255-1258
36. Merli G.J., Herbison G.J., Ditunno J.F., Weitz H.H., Henzes J.H., Park C.H., et al. Deep vein thrombosis: prophylaxis in acute spinal cord injured patients. Arch Phys Med Rehabil 69 (1988) 661-664
37. Frisbie J.H., and Sasahara A.A. Low dose heparin prophylaxis for deep venous thrombosis in acute spinal cord injury patients: a controlled study. Paraplegia 19 (1981) 343-346
38. Watson N. Anti-coagulant therapy in the prevention of venous thrombosis and pulmonary embolism in the spinal cord injury. Paraplegia 16 (1978) 265-269
39. Casas E.R., Sanchez M.P., Arias C.R., and Masip J.P. Prophylaxis of venous thrombosis and pulmonary embolism in patients with acute traumatic spinal cord lesions. Paraplegia 15 (1977) 209-214
40. Dennis J.W., Menawat S., Von Thron J., Fallon Jr. W.F., Vinsant G.O., Laneve L.M., et al. Efficacy of deep venous thrombosis prophylaxis in trauma patients and identification of high-risk groups. J Trauma 35 (1993) 132-138
41. Hebbeler S.L., Marciniak C.M., Crandall S., Chen D., Nussbaum S., and Mendelewski S. Daily vs twice daily enoxaparin in the prevention of venous thromboembolic disorders during rehabilitation following acute spinal cord injury. J Spinal Cord Med 27 (2004) 236-240
42. Chiou-Tan F.Y., Garza H., Chan K.T., Parsons K.C., Donovan W.H., Robertson C.S., et al. Comparison of dalteparin and enoxaparin for deep venous thrombosis prophylaxis in patients with spinal cord injury. Am J Phys Med Rehabil 82 (2003) 678-685
43. Deep K., Jigajinni M.V., McLean A.N., and Fraser M.H. Prophylaxis of thromboembolism in spinal injuries-results of enoxaparin used in 276 patients. Spinal Cord 39 (2001) 88-91
44. Harris S., Chen D., and Green D. Enoxaparin for thromboembolism prophylaxis in spinal injury: preliminary report on experience with 105 patients. Am J Phys Med Rehabil 75 (1996) 326-327
45. Green D., Chen D., Chmiel J.S., Olsen N.K., Berkowitz M., Novick A., et al. Prevention of thromboembolism in spinal cord injury: role of low molecular weight heparin. Arch Phys Med Rehabil 75 (1994) 290-292
46. Ginzburg E., Cohn S.M., Lopez J., Jackowski J., Brown M., and Hameed S.M. Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma. Br J Surg 90 (2003) 1338-1344
47. Paciaroni M., Ageno W., and Agnelli G. Prevention of venous thromboembolism after acute spinal cord injury with low-dose heparin or low-molecular-weight heparin. Thromb Haemost 99 (2008) 978-980
48. Green D., Rossi E.C., Yao J.S., Flinn W.R., and Spies S.M. Deep vein thrombosis in spinal cord injury: effect of prophylaxis with calf compression, aspirin, and dipyridamole. Paraplegia 20 (1982) 227-234
49. Spivack S.B., and Aisen M.L. A comparison of low molecular weight heparin and low dose unfractionated heparin prophylaxis in subacute myelopathy. J Spinal Cord Med 20 (1997) 402-405
50. Glantz M.J., Burger P.C., Friedman A.H., Radtke R.A., Massey E.W., and Schold Jr. S.C. Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology 44 (1994) 2020-2027
51. Kelly J., Rudd A., Lewis R.R., Coshall C., Parmar K., Moody A., et al. Screening for proximal deep vein thrombosis after acute ischemic stroke: a prospective study using clinical factors and plasma D-dimers. J Thromb Haemost 2 (2004) 1321-1326
52. Akman M.N., Cetin N., Bayramoglu M., Isiklar I., and Kilinc S. Value of the D-dimer test in diagnosing deep vein thrombosis in rehabilitation inpatients. Arch Phys Med Rehabil 85 (2004) 1091-1094
53. Harvey R.L., Roth E.J., Yarnold P.R., Durham J.R., and Green D. Deep vein thrombosis in stroke. The use of plasma D-dimer level as a screening test in the rehabilitation setting. Stroke 27 (1996) 1516-1520
54. Akman M.N., Cetin N., Bayramoglu M., Isiklar I., and Kilinc S. Value of the D-dimer test in diagnosing deep vein thrombosis in rehabilitation inpatients. Arch Phys Med Rehabil 85 (2004) 1091-1094
55. Roussi J., Bentolila S., Boudaoud L., Casadevall N., Vallee C., Carlier R., et al. Contribution of D-Dimer determination in the exclusion of deep venous thrombosis in spinal cord injury patients. Spinal Cord 37 (1999) 548-552
56. Kadyan V., Clinchot D.M., and Colachis S.C. Cost-effectiveness of duplex ultrasound surveillance in spinal cord injury. Am J Phys Med Rehabil 83 (2004) 191-197
57. Kadyan V., Clinchot D.M., Mitchell G.L., and Colachis S.C. Surveillance with duplex ultrasound in traumatic spinal cord injury on initial admission to rehabilitation. J Spinal Cord Med 26 (2003) 231-235
58. Powell M., Kirshblum S., and O'Connor K.C. Duplex ultrasound screening for deep vein thrombosis in spinal cord injured patients at rehabilitation admission. Arch Phys Med Rehabil 80 (1999) 1044-1046
59. Burns G.A., Cohn S.M., Frumento R.J., Degutis L.C., and Hammers L. Prospective ultrasound evaluation of venous thrombosis in high-risk trauma patients. J Trauma 35 (1993) 405-408
60. Chu D.A., Ahn J.H., Ragnarsson K.T., Helt J., Folcarelli P., and Ramirez A. Deep venous thrombosis: diagnosis in spinal cord injured patients. Arch Phys Med Rehabil 66 (1985) 365-368